IBDEI3AH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52495,1,3,0)
 ;;=3^DM Type 2 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,52495,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,52495,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,52496,0)
 ;;=E11.22^^194^2540^3
 ;;^UTILITY(U,$J,358.3,52496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52496,1,3,0)
 ;;=3^DM Type 2 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,52496,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,52496,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,52497,0)
 ;;=E11.39^^194^2540^28
 ;;^UTILITY(U,$J,358.3,52497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52497,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,52497,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,52497,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,52498,0)
 ;;=E11.41^^194^2540^6
 ;;^UTILITY(U,$J,358.3,52498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52498,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,52498,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,52498,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,52499,0)
 ;;=E11.42^^194^2540^13
 ;;^UTILITY(U,$J,358.3,52499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52499,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52499,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,52499,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,52500,0)
 ;;=E11.43^^194^2540^2
 ;;^UTILITY(U,$J,358.3,52500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52500,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52500,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,52500,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,52501,0)
 ;;=E11.44^^194^2540^1
 ;;^UTILITY(U,$J,358.3,52501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52501,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,52501,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,52501,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,52502,0)
 ;;=E11.49^^194^2540^8
 ;;^UTILITY(U,$J,358.3,52502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52502,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,52502,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,52502,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,52503,0)
 ;;=E11.59^^194^2540^25
 ;;^UTILITY(U,$J,358.3,52503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52503,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,52503,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,52503,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,52504,0)
 ;;=E11.610^^194^2540^9
 ;;^UTILITY(U,$J,358.3,52504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52504,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,52504,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,52504,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,52505,0)
 ;;=E11.618^^194^2540^26
 ;;^UTILITY(U,$J,358.3,52505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52505,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,52505,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,52505,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,52506,0)
 ;;=E11.621^^194^2540^16
 ;;^UTILITY(U,$J,358.3,52506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52506,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,52506,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,52506,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,52507,0)
 ;;=E11.622^^194^2540^31
 ;;^UTILITY(U,$J,358.3,52507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52507,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
